Stock Region Penny Picks
Stock Region Penny Picks Watchlist Newsletter - Tuesday, March 25, 2025
Stock Region Penny Picks Watchlist Newsletter - Tuesday, March 25, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Please consult with a qualified financial advisor before making any investment decisions.
$POAI - Predictive Oncology
Predictive Oncology has successfully developed predictive models derived from never-before-seen compounds. These models target prevalent cancer indications, including breast, colon, and ovarian cancers. The company's advancements could have meaningful implications for the future of precision medicine and oncology research.
$BLNE - Beeline
Beeline's CEO and Co-Founder, Nick Liuzza, has shown confidence in the company by purchasing $900,000 of stock during its Series G convertible equity round. Notably, this investment carried a 205% premium, as shares were acquired at $5.10 compared to the $1.67 closing price on March 24.
$SISI - Shineco
Shineco has announced the acquisition of a medical device company, signaling a potential strategic expansion into the healthcare sector. Stay tuned for further updates as more details emerge.
$MGRX - Mangoceuticals
Mangoceuticals is branching into the $33 billion diabetes market. The company obtained exclusive rights to market and sell Diabetinol®, a patented and clinically proven product, in the USA and Canada. This strategic move is expected to open significant growth opportunities for MGRX.
$DATS - DatChat
DatChat has officially launched its new social media platform, Myseum, now available for both Apple iOS and Android users. The platform launch could mark an exciting opportunity for expanding the company’s ecosystem and attracting a broader consumer base.
$DM - Desktop Metal
Desktop Metal has announced a significant legal development, with the Delaware Court of Chancery ordering Nano Dimension to complete the acquisition of Desktop Metal. This could potentially consolidate the companies’ positions in the 3D printing sector.
$MBRX - Moleculin Biotech
HC Wainwright & Co. has reiterated a "Buy" rating on Moleculin Biotech, maintaining a price target of $8. With shares currently trading at $1.20, this signals considerable upside potential for investors paying close attention to MBRX.
$CODX - Co-Diagnostics
Co-Diagnostics has been granted U.S. Patent #12258620 for its innovative "Allele-Specific Design of Cooperative Primers." This patent solidifies the company’s role in advancing nucleic acid variant genotyping technology.
$SURG - SurgePays
SurgePays has released its 2024 financial results and provided revenue guidance of over $200 million expected in the next 12 months. Strong financial performance and future projections may boost market interest in this company.
Disclaimer: The stocks mentioned in this newsletter are not recommendations to buy or sell. Please do your own research before making any investment decisions.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net